The presenter highlights a significant positive development in MRNA's cancer therapy trial, indicating strong potential for the stock.
The presenter highlights a significant price increase for MRNA due to a major breakthrough in cancer treatment, indicating strong positive sentiment and a clear recommendation to buy.
The presenter highlights a significant positive development regarding MRNA's personalized cancer therapy trial, which has led to a dramatic price increase. This indicates strong confidence in the stock's potential upside.
The presenter expresses strong enthusiasm about MRNA's recent developments and potential for a price squeeze, indicating a bullish outlook. The language used is also hype-driven, suggesting urgency and excitement.
The presenter mentions shorting MRNA after it failed to hold certain levels, indicating a negative outlook based on technical patterns.
2 of 7 days measured · shaded = no mentions
The blue horizontal line marks the plate's own 30-day score, shown above — it is not an average of the points around it. Each point is that single day's own score, computed the same way but over one day instead of the whole window.
First in this window: Investor's Business Daily · Aug 18, 2026
| BTraderTV Live587k subs | 17 | 253.16 | BULL | <1M |
| BTheChartGuys202k subs | 6 | 54.01 | BULL | <1M |
| BInvestor's Business Daily183k subs | 4 | 38.32 | BULL | Not stated |
| BThe Matt Kohrs Show419k subs | 1 | 30.58 | BULL | <1M |
| BBulls On Wall Street384k subs | 2 | 30.34 | BULL | <1M |
| AMeet Kevin2.1M subs | 3 | 29.56 | NEUT | Not stated |
| CMike Jones Investing79k subs | 1 | 15.66 | BULL | <1M |
| CFuture Investing80k subs | 1 | 12.59 | BULL | <1M |
| ARicky Gutierrez1.2M subs | 1 | 12.59 | BULL | <1M |
| ARoss Cameron - Warrior Trading2.1M subs | 1 | 11.93 | BEAR | <1M |
| BStockCharts TV144k subs | 1 | 10.49 | BULL | <1M |
| BClayTrader640k subs | 1 | 10.49 | BULL | <1M |
| CZacks Investment Research70k subs | 1 | 6.77 | BULL | <1M |